Fiche du document
27 janvier 2021
- doi: 10.53738/REVMED.2021.17.723.0201
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2021.17.723.0201
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33507661
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_25D6152EB2671
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Life, Quality ofCiter ce document
G. Dei Tos et al., « Oncologie [2020 oncology update] », Serveur académique Lausannois, ID : 10.53738/REVMED.2021.17.723.0201
Métriques
Partage / Export
Résumé
The COVID-19 pandemic that has swept around the world in early 2020 has changed our daily practice and habits. Fortunately, however, 2020 also brings its share of new approaches and therapeutic combinations as well as new therapies. These advances are improving the outcomes and quality of life of our patients across the spectrum of oncological diseases. This article summarises the latest oncological advances and novelties for 2020 in the following tumor entities : lung, breast, digestive, gynecological, urological and ENT.